XML 27 R77.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPTIONS (Details) (USD $)
0 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended
Mar. 28, 2014
Oct. 10, 2013
Sep. 10, 2013
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
May 10, 2013
Aug. 17, 2012
Dec. 31, 2013
Minimum
Dec. 31, 2013
Maximum
Mar. 31, 2014
Options
Mar. 31, 2013
Options
Dec. 31, 2013
Options
Dec. 31, 2012
Options
Mar. 31, 2014
Options
Minimum
Dec. 31, 2013
Options
Minimum
Mar. 31, 2014
Options
Maximum
Dec. 31, 2013
Options
Maximum
Jan. 27, 2014
Options
Options issued on January 27, 2014
Mar. 31, 2014
Options
Options issued on January 27, 2014
Jan. 27, 2014
Options
Options issued on January 27, 2014
Immediate vesting
Jan. 27, 2014
Options
Options issued on January 27, 2014
Vesting upon company reporting minimum $10 million in annualized revenue by 2nd anniversary
Jan. 27, 2014
Options
Options issued on January 27, 2014
Vesting upon company reporting minimum $20 million in annualized revenue by 3rd anniversary
Feb. 17, 2014
Options
Options issued on February 17, 2014
Mar. 31, 2014
Options
Options issued on February 17, 2014
Mar. 03, 2014
Options
Options issued on March 3, 2014
Mar. 31, 2014
Options
Options issued on March 3, 2014
Mar. 03, 2014
Options
Options issued on March 3, 2014
Immediate vesting
Mar. 03, 2014
Options
Options issued on March 3, 2014
Vesting every 90 days
Mar. 24, 2014
Options
Options issued on March 24, 2014
Mar. 31, 2014
Options
Options issued on March 24, 2014
Mar. 24, 2014
Options
Options issued on March 24, 2014
One individual
Mar. 31, 2014
Options
Options issued prior to January 1, 2014
Options                                                                    
Options issued and outstanding                       8,712,350   4,485,250 2,820,000                                      
Number of options:                                                                    
Outstanding at beginning of the period (in shares)                       4,485,250 2,820,000 2,820,000                                        
Granted (in shares)                       4,327,100   1,850,000 2,820,000         1,500,000         55,000   250,000       1,522,100   200,000  
Less Exercised (in shares) 100,000 42,250 142,500                 100,000   184,750                                        
Outstanding at the end of the period (in shares)                       8,712,350   4,485,250 2,820,000                                      
Wtd Avg. Exercise Price                                                                    
Outstanding at beginning of the period (in dollars per share)                       $ 0.38 $ 0.25 $ 0.25                                        
Granted (in dollars per share)                       $ 0.43   $ 0.57 $ 0.25                                      
Less Exercised (in dollars per share)                       $ 0.25   $ 0.25                                        
Outstanding at end of the period (in dollars per share)                       $ 0.41   $ 0.38 $ 0.25                                      
Wtd Avg. Remaining Term                                                                    
Outstanding at beginning of the period, wtd Avg. Remaining Term                       4 years 3 months 22 days   3 years 11 months 16 days 4 years 11 months 19 days                                      
Granted, Wtd Avg. Remaining Term                       5 years 2 months 1 day                                            
Outstanding at end of the period, wtd Avg. Remaining Term                       4 years 3 months 22 days   3 years 11 months 16 days 4 years 11 months 19 days                                      
Intrinsic Value                                                                    
Outstanding at beginning of the period, Intrinsic Value (in dollars)                       $ 99,070 $ 0 $ 0                                        
Outstanding at end of the period, Intrinsic Value (in dollars)                       489,225   99,070 0                                      
Significant assumptions used in the valuation                                                                    
Expected term                           3 years 3 months   2 years 8 months 1 day 1 year 5 months 1 day 2 years 10 months 17 days 3 years 3 months                              
Expected volatility (as a percent)                       100.00%   100.00%     100.00%   250.00%                              
Risk-free interest rate (as a percent)                           0.00%   1.54%   1.76%                                
Expected dividend yield (as a percent)                       0.00%   0.00%                                        
Grant date fair value of options                                       274,463         9,752   37,805       675,775      
Share based compensation expense       807,356 86,006 430,138 0         306,134 86,006 648,387 11,309           91,488         582   7,561       60,501   146,002
Number of options awarded                       4,327,100   1,850,000 2,820,000         1,500,000         55,000   250,000       1,522,100   200,000  
Vesting percentage                                           33.33% 33.33% 33.33%         20.00% 20.00%        
Minimum annualized revenues reported by 2nd anniversary from the grant date                                             10,000,000                      
Minimum annualized revenues reported by 3nd anniversary from the grant date                                               20,000,000                    
Exercise Price (in dollars per share)               $ 1.22   $ 0.25 $ 0.60 $ 0.43               $ 0.40         $ 0.305   $ 0.40       $ 0.45      
Vesting period                                                 3 years           3 years      
Common shares for the exercise of options 100,000 42,250 142,500                 100,000   184,750                                        
Common Stock, shares issued 49,496     55,399,839   53,239,369 35,192,045   30,005,185                                                  
Unamortized Share based compensation expense       $ 2,402,590